Life Technologies | LIFE - Loan Capital



Life Technologies reported $602K in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Ardelyx USD 229.21M 78.36M Jun/2025
Biogen USD 6.28B 1.74B Jun/2025
Bristol-Myers Squibb USD 44.47B 1.69B Jun/2025
Cipla INR 2.52B 345.6M Mar/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 9.33B 1.91B Dec/2024
Galapagos EUR 6.05M 1.74M Jun/2025
GlaxoSmithKline GBP 15.3B 1.17B Jun/2025
Grifols EUR 8.68B 155.99M Dec/2024
Life Technologies USD 602K 285K Jun/2025
Novartis USD 24.06B 2.4B Jun/2025
Roche Holding CHF 32.1B 1.94B Dec/2024
United Therapeutics USD 0 0 Mar/2025